View ValuationBiokarpet 将来の成長Future 基準チェック /06現在、 Biokarpetの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Metals and Mining 収益成長18.2%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesNew Risk • May 06New major risk - Revenue and earnings growthEarnings have declined by 13% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 13% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€38.7m market cap, or US$45.6m).New Risk • Apr 13New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.9% net profit margin). Market cap is less than US$100m (€38.8m market cap, or US$45.5m).お知らせ • Feb 20Biokarpet S.A., Annual General Meeting, May 27, 2026Biokarpet S.A., Annual General Meeting, May 27, 2026.分析記事 • Oct 24Capital Allocation Trends At Biokarpet (ATH:BIOKA) Aren't IdealTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...分析記事 • Sep 05Some Shareholders Feeling Restless Over Biokarpet S.A.'s (ATH:BIOKA) P/S RatioThere wouldn't be many who think Biokarpet S.A.'s ( ATH:BIOKA ) price-to-sales (or "P/S") ratio of 0.2x is worth a...Upcoming Dividend • Aug 18Upcoming dividend of €0.02 per shareEligible shareholders must have bought the stock before 25 August 2025. Payment date: 29 August 2025. Trailing yield: 1.0%. Lower than top quartile of Greek dividend payers (4.6%). Lower than average of industry peers (3.7%).New Risk • Jul 14New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Greek stocks, typically moving 5.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.8x net interest cover). Share price has been highly volatile over the past 3 months (5.7% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€43.4m market cap, or US$50.7m).New Risk • Jun 02New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 312% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.8x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€40.9m market cap, or US$46.4m).New Risk • May 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.1% Last year net profit margin: 2.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.9x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.5% average weekly change). Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€41.7m market cap, or US$47.1m).分析記事 • Apr 24Return Trends At Biokarpet (ATH:BIOKA) Aren't AppealingIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...New Risk • Apr 19New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Large one-off items impacting financial results. Market cap is less than US$100m (€37.1m market cap, or US$42.2m).New Risk • Mar 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Greek stocks, typically moving 4.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Share price has been volatile over the past 3 months (4.4% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (€41.5m market cap, or US$43.0m).分析記事 • Feb 28Biokarpet S.A. (ATH:BIOKA) Investors Are Less Pessimistic Than ExpectedThere wouldn't be many who think Biokarpet S.A.'s ( ATH:BIOKA ) price-to-earnings (or "P/E") ratio of 12.5x is worth a...お知らせ • Feb 19Biokarpet S.A., Annual General Meeting, Jun 18, 2025Biokarpet S.A., Annual General Meeting, Jun 18, 2025.お知らせ • Dec 25Biokarpet S.A.(ATSE:BIOKA) dropped from ATHEX Composite IndexBiokarpet S.A. has been dropped from the ATHEX Composite Index.分析記事 • Oct 07We Think That There Are More Issues For Biokarpet (ATH:BIOKA) Than Just Sluggish EarningsThe market wasn't impressed with the soft earnings from Biokarpet S.A. ( ATH:BIOKA ) recently. Our analysis has found...New Risk • Oct 07New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.0x net interest cover). Share price has been highly volatile over the past 3 months (6.4% average weekly change). Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (€39.1m market cap, or US$42.9m).分析記事 • Oct 03Is Biokarpet (ATH:BIOKA) A Risky Investment?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...New Risk • Sep 23New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Greek stocks, typically moving 6.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Share price has been highly volatile over the past 3 months (6.1% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.6% net profit margin). Market cap is less than US$100m (€44.6m market cap, or US$49.8m).お知らせ • Sep 01Biokarpet S.A. to Report First Half, 2024 Results on Sep 27, 2024Biokarpet S.A. announced that they will report first half, 2024 results on Sep 27, 2024Upcoming Dividend • Aug 19Upcoming dividend of €0.02 per shareEligible shareholders must have bought the stock before 26 August 2024. Payment date: 30 August 2024. The average dividend yield among industry peers is 4.3%.New Risk • Aug 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Greek stocks, typically moving 5.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.2x net interest cover). Minor Risks Share price has been volatile over the past 3 months (5.7% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.6% net profit margin). Significant insider selling over the past 3 months (€644k sold). Market cap is less than US$100m (€47.3m market cap, or US$52.1m).New Risk • Apr 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.7x net interest cover). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (€69.6m market cap, or US$73.9m).分析記事 • Apr 13The Return Trends At Biokarpet (ATH:BIOKA) Look PromisingDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...お知らせ • Apr 01Biokarpet S.A. to Report Q4, 2023 Results on Apr 30, 2024Biokarpet S.A. announced that they will report Q4, 2023 results on Apr 30, 2024Valuation Update With 7 Day Price Move • Nov 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €2.67, the stock trades at a trailing P/E ratio of 15.3x. Average trailing P/E is 10x in the Metals and Mining industry in Europe. Total returns to shareholders of 265% over the past three years.分析記事 • Nov 09Biokarpet's (ATH:BIOKA) Returns On Capital Are Heading HigherFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...分析記事 • Oct 10Biokarpet (ATH:BIOKA) Seems To Be Using A Lot Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Reported Earnings • Oct 05First half 2023 earnings released: EPS: €0.091 (vs €0.29 in 1H 2022)First half 2023 results: EPS: €0.091 (down from €0.29 in 1H 2022). Revenue: €118.3m (down 10.0% from 1H 2022). Net income: €2.18m (down 69% from 1H 2022). Profit margin: 1.8% (down from 5.3% in 1H 2022). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has only increased by 50% per year, which means it is significantly lagging earnings growth.New Risk • Oct 01New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 29% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.9x net interest cover). Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (€53.0m market cap, or US$56.0m).Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €2.21, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 8x in the Metals and Mining industry in Greece. Total returns to shareholders of 252% over the past three years.Board Change • Sep 26No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. No independent directors (6 non-independent directors). Executive Director Panagiotis Mauromatis was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.分析記事 • Sep 09Biokarpet S.A. (ATH:BIOKA) Doing What It Can To Lift SharesBiokarpet S.A.'s ( ATH:BIOKA ) price-to-earnings (or "P/E") ratio of 7.4x might make it look like a buy right now...お知らせ • Sep 01Biokarpet S.A. to Report First Half, 2023 Results on Sep 29, 2023Biokarpet S.A. announced that they will report first half, 2023 results on Sep 29, 2023Upcoming Dividend • Aug 21Inaugural dividend of €0.015 per shareEligible shareholders must have bought the stock before 28 August 2023. Payment date: 01 September 2023. This is the first dividend for Biokarpet since going public. The average dividend yield among industry peers is 8.8%.分析記事 • Jul 11Biokarpet (ATH:BIOKA) Might Have The Makings Of A Multi-BaggerWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...お知らせ • Jun 01Biokarpet S.A., Annual General Meeting, Jun 21, 2023Biokarpet S.A., Annual General Meeting, Jun 21, 2023, at 11:00 E. Europe Standard Time. Location: LARISA, 5th KLM LARISA-ATHENS Athens GreeceValuation Update With 7 Day Price Move • Mar 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €2.08, the stock trades at a trailing P/E ratio of 5.3x. Average trailing P/E is 3x in the Metals and Mining industry in Greece. Total returns to shareholders of 285% over the past three years.分析記事 • Mar 23Biokarpet (ATH:BIOKA) Is Doing The Right Things To Multiply Its Share PriceIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...Valuation Update With 7 Day Price Move • Feb 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €1.94, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 3x in the Metals and Mining industry in Greece. Total returns to shareholders of 55% over the past three years.Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. No independent directors (6 non-independent directors). Executive Director Panagiotis Mauromatis was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Sep 30First half 2022 earnings released: EPS: €0.29 (vs €0.072 in 1H 2021)First half 2022 results: EPS: €0.29 (up from €0.072 in 1H 2021). Revenue: €131.5m (up 46% from 1H 2021). Net income: €6.98m (up 305% from 1H 2021). Profit margin: 5.3% (up from 1.9% in 1H 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Sep 15Investor sentiment improved over the past weekAfter last week's 17% share price gain to €1.55, the stock trades at a trailing P/E ratio of 8.8x. Average trailing P/E is 3x in the Metals and Mining industry in Greece. Total returns to shareholders of 86% over the past three years.分析記事 • Sep 14Do Biokarpet's (ATH:BIOKA) Earnings Warrant Your Attention?Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...お知らせ • Sep 02Biokarpet S.A. to Report First Half, 2022 Results on Sep 28, 2022Biokarpet S.A. announced that they will report first half, 2022 results on Sep 28, 2022分析記事 • Jun 04Here's Why I Think Biokarpet (ATH:BIOKA) Is An Interesting StockIt's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...お知らせ • Jun 01Biokarpet S.A., Annual General Meeting, Jun 22, 2022Biokarpet S.A., Annual General Meeting, Jun 22, 2022, at 09:00 Coordinated Universal Time. Location: LARISA, 5th KLM LARISSA-ATHENS Athens GreeceReported Earnings • May 05Full year 2021 earnings released: EPS: €0.17 (vs €0.009 in FY 2020)Full year 2021 results: EPS: €0.17 (up from €0.009 in FY 2020). Revenue: €187.3m (up 52% from FY 2020). Net income: €4.21m (up €3.99m from FY 2020). Profit margin: 2.2% (up from 0.2% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. No independent directors (6 non-independent directors). Executive Director Panagiotis Mauromatis was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.お知らせ • Apr 01Biokarpet S.A. to Report Fiscal Year 2021 Results on Apr 29, 2022Biokarpet S.A. announced that they will report fiscal year 2021 results on Apr 29, 2022Valuation Update With 7 Day Price Move • Mar 10Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €1.35, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 5x in the Metals and Mining industry in Greece. Total returns to shareholders of 135% over the past three years.Valuation Update With 7 Day Price Move • Feb 16Investor sentiment improved over the past weekAfter last week's 22% share price gain to €1.81, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 5x in the Metals and Mining industry in Greece. Total returns to shareholders of 174% over the past three years.分析記事 • Dec 09Investors Will Want Biokarpet's (ATH:BIOKA) Growth In ROCE To PersistIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Valuation Update With 7 Day Price Move • Dec 09Investor sentiment improved over the past weekAfter last week's 15% share price gain to €1.67, the stock trades at a trailing P/E ratio of 9.2x. Average trailing P/E is 5x in the Metals and Mining industry in Greece. Total returns to shareholders of 209% over the past three years.分析記事 • Oct 21Is Biokarpet (ATH:BIOKA) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Oct 01First half 2021 earnings released: EPS €0.072 (vs €0.10 loss in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €90.1m (up 55% from 1H 2020). Net income: €1.72m (up €4.13m from 1H 2020). Profit margin: 1.9% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 45% per year, which means it is significantly lagging earnings growth.分析記事 • Jun 03Biokarpet (ATH:BIOKA) Is Experiencing Growth In Returns On CapitalTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...Reported Earnings • Apr 28Full year 2020 earnings released: EPS €0.009 (vs €0.052 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €123.2m (down 2.0% from FY 2019). Net income: €218.8k (down 82% from FY 2019). Profit margin: 0.2% (down from 1.0% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth.分析記事 • Feb 23Does Biokarpet (ATH:BIOKA) Have The Makings Of A Multi-Bagger?Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...Is New 90 Day High Low • Dec 07New 90-day high: €0.81The company is up 19% from its price of €0.68 on 08 September 2020. The Greek market is up 17% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Metals and Mining industry, which is up 33% over the same period.Is New 90 Day High Low • Oct 27New 90-day high: €0.76The company is up 26% from its price of €0.60 on 29 July 2020. The Greek market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 5.0% over the same period.Reported Earnings • Oct 04First half earnings releasedOver the last 12 months the company has reported total losses of €1.83m, with earnings decreasing by €3.50m from the prior year. Total revenue was €115.7m over the last 12 months, down 9.6% from the prior year.お知らせ • Sep 06Biokarpet S.A. to Report First Half, 2020 Results on Sep 30, 2020Biokarpet S.A. announced that they will report first half, 2020 results on Sep 30, 2020 このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Biokarpet は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測ATSE:BIOKA - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20252133-103N/A9/30/20252123-310N/A6/30/20252112317N/A3/31/20252081-114N/A12/31/20242050-511N/A9/30/20242012-97N/A6/30/20241973-133N/A3/31/20242044-78N/A12/31/20232105-112N/A9/30/20232145315N/A6/30/20232184717N/A3/31/20232257111N/A12/31/20222319-65N/A9/30/20222309-75N/A6/30/20222299-95N/A3/31/20222087-67N/A12/31/20211874-39N/A9/30/20211714-64N/A6/30/20211554-90N/A3/31/20211392-11-3N/A12/31/20201230-14-5N/A9/30/2020119-1-52N/A6/30/2020116-249N/A3/31/2020121039N/A12/31/2019126139N/A9/30/20191271N/A8N/A6/30/20191282N/A6N/A3/31/20191241N/A5N/A12/31/20181190N/A3N/A9/30/20181160N/A2N/A6/30/2018113-1N/A0N/A3/31/2018109-1N/A1N/A12/31/2017105-1N/A2N/A9/30/2017100-1N/A2N/A6/30/2017950N/A2N/A3/31/201790-1N/A3N/A12/31/201686-2N/A3N/A9/30/201687-3N/A5N/A6/30/201686-4N/A6N/A3/31/201685-4N/A5N/A12/31/201581-4N/A2N/A9/30/201580-3N/A3N/A6/30/201578-4N/A1N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: BIOKAの予測収益成長が 貯蓄率 ( 3.2% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: BIOKAの収益がGreek市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: BIOKAの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: BIOKAの収益がGreek市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: BIOKAの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: BIOKAの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/24 15:55終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Biokarpet S.A. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
New Risk • May 06New major risk - Revenue and earnings growthEarnings have declined by 13% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 13% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€38.7m market cap, or US$45.6m).
New Risk • Apr 13New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.9% net profit margin). Market cap is less than US$100m (€38.8m market cap, or US$45.5m).
お知らせ • Feb 20Biokarpet S.A., Annual General Meeting, May 27, 2026Biokarpet S.A., Annual General Meeting, May 27, 2026.
分析記事 • Oct 24Capital Allocation Trends At Biokarpet (ATH:BIOKA) Aren't IdealTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
分析記事 • Sep 05Some Shareholders Feeling Restless Over Biokarpet S.A.'s (ATH:BIOKA) P/S RatioThere wouldn't be many who think Biokarpet S.A.'s ( ATH:BIOKA ) price-to-sales (or "P/S") ratio of 0.2x is worth a...
Upcoming Dividend • Aug 18Upcoming dividend of €0.02 per shareEligible shareholders must have bought the stock before 25 August 2025. Payment date: 29 August 2025. Trailing yield: 1.0%. Lower than top quartile of Greek dividend payers (4.6%). Lower than average of industry peers (3.7%).
New Risk • Jul 14New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Greek stocks, typically moving 5.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.8x net interest cover). Share price has been highly volatile over the past 3 months (5.7% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€43.4m market cap, or US$50.7m).
New Risk • Jun 02New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 312% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.8x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€40.9m market cap, or US$46.4m).
New Risk • May 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.1% Last year net profit margin: 2.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.9x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.5% average weekly change). Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€41.7m market cap, or US$47.1m).
分析記事 • Apr 24Return Trends At Biokarpet (ATH:BIOKA) Aren't AppealingIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
New Risk • Apr 19New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Large one-off items impacting financial results. Market cap is less than US$100m (€37.1m market cap, or US$42.2m).
New Risk • Mar 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Greek stocks, typically moving 4.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Share price has been volatile over the past 3 months (4.4% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (€41.5m market cap, or US$43.0m).
分析記事 • Feb 28Biokarpet S.A. (ATH:BIOKA) Investors Are Less Pessimistic Than ExpectedThere wouldn't be many who think Biokarpet S.A.'s ( ATH:BIOKA ) price-to-earnings (or "P/E") ratio of 12.5x is worth a...
お知らせ • Feb 19Biokarpet S.A., Annual General Meeting, Jun 18, 2025Biokarpet S.A., Annual General Meeting, Jun 18, 2025.
お知らせ • Dec 25Biokarpet S.A.(ATSE:BIOKA) dropped from ATHEX Composite IndexBiokarpet S.A. has been dropped from the ATHEX Composite Index.
分析記事 • Oct 07We Think That There Are More Issues For Biokarpet (ATH:BIOKA) Than Just Sluggish EarningsThe market wasn't impressed with the soft earnings from Biokarpet S.A. ( ATH:BIOKA ) recently. Our analysis has found...
New Risk • Oct 07New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.0x net interest cover). Share price has been highly volatile over the past 3 months (6.4% average weekly change). Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (€39.1m market cap, or US$42.9m).
分析記事 • Oct 03Is Biokarpet (ATH:BIOKA) A Risky Investment?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
New Risk • Sep 23New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Greek stocks, typically moving 6.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Share price has been highly volatile over the past 3 months (6.1% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.6% net profit margin). Market cap is less than US$100m (€44.6m market cap, or US$49.8m).
お知らせ • Sep 01Biokarpet S.A. to Report First Half, 2024 Results on Sep 27, 2024Biokarpet S.A. announced that they will report first half, 2024 results on Sep 27, 2024
Upcoming Dividend • Aug 19Upcoming dividend of €0.02 per shareEligible shareholders must have bought the stock before 26 August 2024. Payment date: 30 August 2024. The average dividend yield among industry peers is 4.3%.
New Risk • Aug 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Greek stocks, typically moving 5.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.2x net interest cover). Minor Risks Share price has been volatile over the past 3 months (5.7% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.6% net profit margin). Significant insider selling over the past 3 months (€644k sold). Market cap is less than US$100m (€47.3m market cap, or US$52.1m).
New Risk • Apr 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.7x net interest cover). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (€69.6m market cap, or US$73.9m).
分析記事 • Apr 13The Return Trends At Biokarpet (ATH:BIOKA) Look PromisingDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...
お知らせ • Apr 01Biokarpet S.A. to Report Q4, 2023 Results on Apr 30, 2024Biokarpet S.A. announced that they will report Q4, 2023 results on Apr 30, 2024
Valuation Update With 7 Day Price Move • Nov 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €2.67, the stock trades at a trailing P/E ratio of 15.3x. Average trailing P/E is 10x in the Metals and Mining industry in Europe. Total returns to shareholders of 265% over the past three years.
分析記事 • Nov 09Biokarpet's (ATH:BIOKA) Returns On Capital Are Heading HigherFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
分析記事 • Oct 10Biokarpet (ATH:BIOKA) Seems To Be Using A Lot Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Reported Earnings • Oct 05First half 2023 earnings released: EPS: €0.091 (vs €0.29 in 1H 2022)First half 2023 results: EPS: €0.091 (down from €0.29 in 1H 2022). Revenue: €118.3m (down 10.0% from 1H 2022). Net income: €2.18m (down 69% from 1H 2022). Profit margin: 1.8% (down from 5.3% in 1H 2022). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has only increased by 50% per year, which means it is significantly lagging earnings growth.
New Risk • Oct 01New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 29% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.9x net interest cover). Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (€53.0m market cap, or US$56.0m).
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €2.21, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 8x in the Metals and Mining industry in Greece. Total returns to shareholders of 252% over the past three years.
Board Change • Sep 26No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. No independent directors (6 non-independent directors). Executive Director Panagiotis Mauromatis was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
分析記事 • Sep 09Biokarpet S.A. (ATH:BIOKA) Doing What It Can To Lift SharesBiokarpet S.A.'s ( ATH:BIOKA ) price-to-earnings (or "P/E") ratio of 7.4x might make it look like a buy right now...
お知らせ • Sep 01Biokarpet S.A. to Report First Half, 2023 Results on Sep 29, 2023Biokarpet S.A. announced that they will report first half, 2023 results on Sep 29, 2023
Upcoming Dividend • Aug 21Inaugural dividend of €0.015 per shareEligible shareholders must have bought the stock before 28 August 2023. Payment date: 01 September 2023. This is the first dividend for Biokarpet since going public. The average dividend yield among industry peers is 8.8%.
分析記事 • Jul 11Biokarpet (ATH:BIOKA) Might Have The Makings Of A Multi-BaggerWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
お知らせ • Jun 01Biokarpet S.A., Annual General Meeting, Jun 21, 2023Biokarpet S.A., Annual General Meeting, Jun 21, 2023, at 11:00 E. Europe Standard Time. Location: LARISA, 5th KLM LARISA-ATHENS Athens Greece
Valuation Update With 7 Day Price Move • Mar 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €2.08, the stock trades at a trailing P/E ratio of 5.3x. Average trailing P/E is 3x in the Metals and Mining industry in Greece. Total returns to shareholders of 285% over the past three years.
分析記事 • Mar 23Biokarpet (ATH:BIOKA) Is Doing The Right Things To Multiply Its Share PriceIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...
Valuation Update With 7 Day Price Move • Feb 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €1.94, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 3x in the Metals and Mining industry in Greece. Total returns to shareholders of 55% over the past three years.
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. No independent directors (6 non-independent directors). Executive Director Panagiotis Mauromatis was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Sep 30First half 2022 earnings released: EPS: €0.29 (vs €0.072 in 1H 2021)First half 2022 results: EPS: €0.29 (up from €0.072 in 1H 2021). Revenue: €131.5m (up 46% from 1H 2021). Net income: €6.98m (up 305% from 1H 2021). Profit margin: 5.3% (up from 1.9% in 1H 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Sep 15Investor sentiment improved over the past weekAfter last week's 17% share price gain to €1.55, the stock trades at a trailing P/E ratio of 8.8x. Average trailing P/E is 3x in the Metals and Mining industry in Greece. Total returns to shareholders of 86% over the past three years.
分析記事 • Sep 14Do Biokarpet's (ATH:BIOKA) Earnings Warrant Your Attention?Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
お知らせ • Sep 02Biokarpet S.A. to Report First Half, 2022 Results on Sep 28, 2022Biokarpet S.A. announced that they will report first half, 2022 results on Sep 28, 2022
分析記事 • Jun 04Here's Why I Think Biokarpet (ATH:BIOKA) Is An Interesting StockIt's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
お知らせ • Jun 01Biokarpet S.A., Annual General Meeting, Jun 22, 2022Biokarpet S.A., Annual General Meeting, Jun 22, 2022, at 09:00 Coordinated Universal Time. Location: LARISA, 5th KLM LARISSA-ATHENS Athens Greece
Reported Earnings • May 05Full year 2021 earnings released: EPS: €0.17 (vs €0.009 in FY 2020)Full year 2021 results: EPS: €0.17 (up from €0.009 in FY 2020). Revenue: €187.3m (up 52% from FY 2020). Net income: €4.21m (up €3.99m from FY 2020). Profit margin: 2.2% (up from 0.2% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. No independent directors (6 non-independent directors). Executive Director Panagiotis Mauromatis was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
お知らせ • Apr 01Biokarpet S.A. to Report Fiscal Year 2021 Results on Apr 29, 2022Biokarpet S.A. announced that they will report fiscal year 2021 results on Apr 29, 2022
Valuation Update With 7 Day Price Move • Mar 10Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €1.35, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 5x in the Metals and Mining industry in Greece. Total returns to shareholders of 135% over the past three years.
Valuation Update With 7 Day Price Move • Feb 16Investor sentiment improved over the past weekAfter last week's 22% share price gain to €1.81, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 5x in the Metals and Mining industry in Greece. Total returns to shareholders of 174% over the past three years.
分析記事 • Dec 09Investors Will Want Biokarpet's (ATH:BIOKA) Growth In ROCE To PersistIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Valuation Update With 7 Day Price Move • Dec 09Investor sentiment improved over the past weekAfter last week's 15% share price gain to €1.67, the stock trades at a trailing P/E ratio of 9.2x. Average trailing P/E is 5x in the Metals and Mining industry in Greece. Total returns to shareholders of 209% over the past three years.
分析記事 • Oct 21Is Biokarpet (ATH:BIOKA) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Oct 01First half 2021 earnings released: EPS €0.072 (vs €0.10 loss in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €90.1m (up 55% from 1H 2020). Net income: €1.72m (up €4.13m from 1H 2020). Profit margin: 1.9% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 45% per year, which means it is significantly lagging earnings growth.
分析記事 • Jun 03Biokarpet (ATH:BIOKA) Is Experiencing Growth In Returns On CapitalTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Reported Earnings • Apr 28Full year 2020 earnings released: EPS €0.009 (vs €0.052 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €123.2m (down 2.0% from FY 2019). Net income: €218.8k (down 82% from FY 2019). Profit margin: 0.2% (down from 1.0% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth.
分析記事 • Feb 23Does Biokarpet (ATH:BIOKA) Have The Makings Of A Multi-Bagger?Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...
Is New 90 Day High Low • Dec 07New 90-day high: €0.81The company is up 19% from its price of €0.68 on 08 September 2020. The Greek market is up 17% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Metals and Mining industry, which is up 33% over the same period.
Is New 90 Day High Low • Oct 27New 90-day high: €0.76The company is up 26% from its price of €0.60 on 29 July 2020. The Greek market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 5.0% over the same period.
Reported Earnings • Oct 04First half earnings releasedOver the last 12 months the company has reported total losses of €1.83m, with earnings decreasing by €3.50m from the prior year. Total revenue was €115.7m over the last 12 months, down 9.6% from the prior year.
お知らせ • Sep 06Biokarpet S.A. to Report First Half, 2020 Results on Sep 30, 2020Biokarpet S.A. announced that they will report first half, 2020 results on Sep 30, 2020